WALTHAM, Mass., Feb. 15, 2022 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on bioprocessing technology leadership, today announced the commercial launch of ...
In the downstream portion of any bioprocess, one must pick through the dross before one can seize the gold—the biotherapeutic that the bioprocess was always meant to generate. Unfortunately, the dross ...
Adeno-associated vectors (AAV) have become the workhorse for gene therapy delivery over the last two decades. With the constantly growing number of clinical trials, the demand for vectors has ...
Many viral vectors have shown promise as gene delivery systems in small-animal studies 1. As these vectors progress to the next level of phase I and phase II clinical studies, it is important to ...
Adeno-associated viruses (AAVs) have emerged in recent years as a crucial tool in clinical gene therapies, offering low pathogenicity and long-lived gene expression in target cells. AAVs are simple ...
This first-of-its-kind reagent combines the best of both affinity- and size- based separations using a recombinant protein with engineered affinity and unique liquid-phase separation capabilities.
CARLSBAD, Calif., July 7, 2021 /PRNewswire/ -- For gene therapy developers seeking to rapidly and efficiently scale production, a set of solutions is now available from Thermo Fisher Scientific to ...
Markets Insider and Business Insider Editorial Teams were not involved in the creation of this post. Repligen NewsMORE Related Stocks Indices Commodities Currencies Stocks ...
RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)-- Isolere Bio by Donaldson, an innovative bioprocessing technology provider, proudly announces the availability of its manufacturing-grade IsoTag™ AAV ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results